PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 237 of 640

Advanced search
🌍discoverynews.google.comTier 2 · Trade media

BioMarin spends up to $490m for Alesta’s bone disease candidate

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Experts scrutinize Huidagene’s disclosures after patient death

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump nominates aide Heidi Overton to lead US Food and Drug Administration

BBCOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

Ars TechnicaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rockville biopharma firm slashes workforce by nearly two-thirds after drug trial fails

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump picks Dr. Heidi Overton, a top White House aide, to lead the Food and Drug Administration

San Bernardino SunOriginal source
🇯🇵Industrynippon-shinyaku.co.jpTier 1 · Company source

譲渡制限付株式報酬としての自己株式の処分の払込完了に関するお知らせ

Nippon Shinyaku NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump picks Heidi Overton to lead FDA, pledges faster cures and lower drug prices

Business UpturnOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New 'landmark' drug shown to prevent recurrence of deadly melanoma

ABC News & Headlines – Australian Broadcasting CorporationOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fake, Expired Medicines Worth Rs 5 Crore Seized Repacking Unit In Bengaluru

NDTVOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Accepts Review of a Pancreatic Cancer Pill Already Reaching Patients Through an Expanded Access Program

inklOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ecopipam's D1 Receptor Approach Signals New Pediatric Neuroscience Pathway

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Is Raising Concerns About Unapproved GLP-1 Weight-Loss Drugs

The Well NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Gridiron Backs the Back Office Behind Biotech

Private Equity ProfessionalOriginal source
🇺🇸Researchnews.nm.orgTier 2 · Direct publisher

Northwestern Medicine Expands Cardiovascular Services to Tinley Park

Northwestern MedicineOriginal source
🇺🇸universitynews.mit.eduTier 2 · Direct publisher

Flipping the script on biology education, and scaling it up

MIT Biology NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Guggenheim raises Amylyx stock price target on trial results By Investing.com

Investing.com South AfricaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump Nominates White House Aide Dr. Heidi Overton to Lead Embattled FDA

streamlinefeed.co.keOriginal source
🇯🇵Researchriken.jpTier 2 · Direct publisher

Meet RIKEN's new laboratory heads (August 2026)

RIKENOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Fluidics enhances Solid Phase Extraction with new patented device

Scientist LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks Are Booming. What This Top Fund Is Buying Now.

Barron'sOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Nurses Need to Know About FDA-Approved Iberdomide in Multiple Myeloma

Oncology Nursing NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CTT Pharmaceutical (CTTH) CEO buys 10,000 more shares

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Shortage Leads to Nationwide Black Market

IranWireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Connor Broadley bought a biotech ETF for first time

CitywireOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Trump taps White House aide Heidi Overton as nominee for next FDA commissioner

Fierce BiotechOriginal source
🇨🇭CROpsi-cro.comTier 2 · Direct publisher

Placebo response in IBD trials

PSI CROOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna Stock Price Today: Moderna Stock Rockets Higher After Positive Cancer Vaccine Trial – Here’s What Investors Should Know

The Sunday GuardianOriginal source
🇺🇰Researchmed.cam.ac.ukTier 2 · Direct publisher

Cambridge researchers develop new approach to study inflammatory lung diseases

University of Cambridge - Clinical Medicine NewsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Tolerance Bio jumps into phase 2 with $260M deal for thymus-targeting fusion protein

fiercebiotech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

mRNA cancer vaccine trial win ripples across biotech and oncology stocks

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna and Merck Expose Groundbreaking mRNA Cancer Vaccine Efficacy in Phase 3

streamlinefeed.co.keOriginal source
🌍discoverynews.google.comTier 2 · Trade media

New Biotech-Academia Partnership Approaches to Empower the Drug Development Ecosystem

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

QT9 Software updates for medical device, pharmaceutical and biotechnology teams

Scientist LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI In Pharmacovigilance: The Commercial and Market-Access Imperative

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx (RARE) Stock Could Stay Fully Priced On Setrusumab Regulatory Talks

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cathay Biotech: Revenue and net profit surged on business expansion and new product lines, with robust R&D investment

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melano

BioSpaceOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: In-silico Development- and Clinical-Trial-Platform for Testing in-situ Tissue Engineered Heart Valves

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Immune Niches for Cancer ImmunoTherapy Enhancement

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Ultra-fast Antimicrobial Susceptibility Test for diagnosing antimicrobial resistance to provide personalized antibiotic treatments

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Optoelectronic medicine - nerve cell regulation with light

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Caught in the Middle: Chinese Biotech Firms’ Divergent Responses to U.S. Sanctions

Carnegie Endowment for International PeaceOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The biotech bi-weekly: NIH maternal health research prizes, a virtual human cell model and chondrocyte spheroids to treat joint degeneration

BioTechniquesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The New Frontier of Pharmaceutical Growth

Mexico Business NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GenBio Inc. Highlights Strategic Importance of Emerging Biotechnology Amid Expansion of U.S. Pharmaceutical Investment

EIN NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna Shares Skyrocket Up to 90% as Its mRNA Cancer Vaccine With Merck Succeeds in Late-Stage Trial

International Business Times AustraliaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oncolytics Biotech (NASDAQ:ONCY) Price Target Cut to $5.00 by Analysts at HC Wainwright

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna Surges Over 100% Pre-Market as Phase 3 Cancer Vaccine Trial With Merck Succeeds

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VRAX Stock Whipsaws As Traders Target Volatile Biotech Play

StocksToTradeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

High Quality Undervalued Stocks Backed By Cash Flow In Japan

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biodexa's trial for a hereditary polyp condition passes halfway at 87 recruits

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ENCLONY Accelerates Global Expansion with Advanced Pharmaceutical Vision Inspection Technology

EIN NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jefferies Adjusts Genscript Biotech's Price Target to HK$30 From HK$15.50, Keeps at Buy

marketscreener.comOriginal source